@misc{mathis_schoolfield_gross_gruen_dorman_2024, title={A Systematic Review of the Efficacy of Compression Wraps as an Anxiolytic in Domesticated Dogs}, volume={14}, ISSN={["2076-2615"]}, DOI={10.3390/ani14233445}, abstractNote={Many domesticated dogs show signs of anxiety, negatively impacting their own and their owner’s mental and physical health. A systematic review evaluating whether pressure wraps decrease clinical signs of anxiety in dogs was completed to identify relevant studies. The main outcomes of interest included behavioral and physiological measures. A total of 229 studies were identified, of which four met the inclusion criteria. Commercially available pressure wraps and a telemetry vest were used in the reviewed studies. Three experimental studies included brief exposure to recorded firecracker or thunderstorm sounds or separation from their owner as anxiety-invoking stimuli. A non-experimental study evaluated the use of pressure wraps for dogs with thunderstorm phobia living in their home environment exposed to naturally occurring thunderstorms. The risk of bias in domains related to the blinding of investigators or study participants was generally high. Domains with moderate risk of bias often reflected incomplete reporting of research methods and imprecision due to small sample sizes. Most studies reported minimal benefits on behavior or heart rate in the absence of adverse side effects. Our review suggests there is weak and limited evidence to support the beneficial effect of pressure wraps in reducing physiological or behavioral signs of anxiety. Confidence in the available literature is low due to the moderate-to-high risks of bias and inconsistent findings. Further studies are needed regarding the efficacy of these products.}, number={23}, journal={ANIMALS}, author={Mathis, Savannah and Schoolfield, Suzie and Gross, Peggy and Gruen, Margaret and Dorman, David C.}, year={2024}, month={Dec} } @article{goehring_dorman_osterrieder_burgess_dougherty_gross_neinast_pusterla_soboll-hussey_lunn_2024, title={Pharmacologic interventions for the treatment of equine herpesvirus-1 in domesticated horses: A systematic review}, volume={2}, ISSN={["1939-1676"]}, url={https://doi.org/10.1111/jvim.17016}, DOI={10.1111/jvim.17016}, abstractNote={AbstractBackgroundEquine herpes virus type 1 (EHV‐1) infection in horses is associated with upper respiratory disease, neurological disease, abortions, and neonatal death.Review QuestionDoes pharmacological therapy decrease either the incidence or severity of disease or infection caused by EHV‐1 in domesticated horses?MethodsA systematic review was preformed searching AGRICOLA, CAB Abstracts, Cochrane, PubMed, Web of Science, and WHO Global Health Index Medicus Regional Databases to identify articles published before February 15, 2021. Selection criteria were original research reports published in peer reviewed journals, and studies investigating in vivo use of therapeutic agents for prevention or treatment of EHV‐1 in horses. Outcomes assessed included measures related to clinical outcomes that reflect symptomatic EHV‐1 infection or virus infection. We evaluated risk of bias and performed a GRADE evaluation of the quality of evidence for interventions.ResultsA total of 7009 unique studies were identified, of which 9 met the inclusion criteria. Two studies evaluated valacyclovir or small interfering RNAs, and single studies evaluated the use of a Parapoxvirus ovis‐based immunomodulator, human alpha interferon, an herbal supplement, a cytosine analog, and heparin. The level of evidence ranged between randomized controlled studies and observational trials. The risk of bias was moderate to high and sample sizes were small. Most studies reported either no benefit or minimal efficacy of the intervention tested.Conclusions and Clinical ImportanceOur review indicates minimal or limited benefit either as a prophylactic or post‐exposure treatment for any of the studied interventions in the mitigation of EHV‐1‐associated disease outcome.}, journal={JOURNAL OF VETERINARY INTERNAL MEDICINE}, author={Goehring, Lutz and Dorman, David C. and Osterrieder, Klaus and Burgess, Brandy A. and Dougherty, Kelsie and Gross, Peggy and Neinast, Claire and Pusterla, Nicola and Soboll-Hussey, Gisela and Lunn, David P.}, year={2024}, month={Feb} } @article{lunn_burgess_dorman_goehring_gross_osterrieder_pusterla_hussey_2024, title={Updated ACVIM consensus statement on equine herpesvirus-1}, volume={3}, ISSN={["1939-1676"]}, url={https://doi.org/10.1111/jvim.17047}, DOI={10.1111/jvim.17047}, abstractNote={AbstractEquine herpesvirus‐1 (EHV‐1) is a highly prevalent and frequently pathogenic infection of equids. The most serious clinical consequences of infection are abortion and equine herpesvirus myeloencephalopathy (EHM). The previous consensus statement was published in 2009 and considered pathogenesis, strain variation, epidemiology, diagnostic testing, vaccination, outbreak prevention and control, and treatment. A recent survey of American College of Veterinary Internal Medicine large animal diplomates identified the need for a revision to this original consensus statement. This updated consensus statement is underpinned by 4 systematic reviews that addressed key questions concerning vaccination, pharmaceutical treatment, pathogenesis, and diagnostic testing. Evidence for successful vaccination against, or effective treatment of EHV‐1 infection was limited, and improvements in experimental design and reporting of results are needed in future studies of this important disease. This consensus statement also updates the topics considered previously in 2009.}, journal={JOURNAL OF VETERINARY INTERNAL MEDICINE}, author={Lunn, David P. and Burgess, Brandy A. and Dorman, David C. and Goehring, Lutz S. and Gross, Peggy and Osterrieder, Klaus and Pusterla, Nicola and Hussey, Gisela Soboll}, year={2024}, month={Mar} } @article{gross_2023, title={"How didst thou come beneath the murky darkness?": sense-making in light of the ancient Greeks and in the spirit of Hegel}, volume={4}, ISSN={1758-7379}, url={https://doi.org/10.1108/JD-07-2022-0152}, DOI={10.1108/JD-07-2022-0152}, abstractNote={PurposeThis piece explores the philosophical origins of sense-making as defined in Brenda Dervin’s methodology.Design/methodology/approachThis conceptual paper locates the origins of sense-making's rich ontological, epistemological and etymological heritage to the Classical Greece and the Pre-Socratic period. The Greek origins of sense-making‘s philosophical undercurrents surface again in Hegel’s Phenomenology of Spirit before the idea is picked up again in twentieth century philosophy and library science.FindingsThis is a conceptual paper and no empirical findings are presented.Originality/valueThis paper makes an original contribution to the study of information seeking and to sense making theory and methodology.}, number={6}, journal={JOURNAL OF DOCUMENTATION}, author={Gross, Margaret}, year={2023}, month={Apr}, pages={1369–1379} } @article{soboll-hussey_dorman_burgess_goehring_gross_neinast_osterrieder_pusterla_lunn_2023, title={Relationship between equine herpesvirus-1 viremia and abortion or equine herpesvirus myeloencephalopathy in domesticated horses: A systematic review}, volume={12}, ISSN={["1939-1676"]}, url={https://doi.org/10.1111/jvim.16948}, DOI={10.1111/jvim.16948}, abstractNote={AbstractBackgroundEquine herpes virus type 1 (EHV‐1) infection in horses is associated with upper respiratory disease, neurological disease, abortions, and neonatal death.ObjectiveTo determine if there is an association between the level and duration of EHV‐1 viremia and either abortion or equine herpesvirus myeloencephalopathy (EHM) in domesticated horses?MethodsA systematic review was performed searching numerous databases to identify peer reviewed reports that evaluated viremia and EHM, or viremia and abortion published before January 19, 2021. Randomized controlled trials and observational studies were assessed for risk of bias or publication quality.ResultsA total of 189 unique studies were identified, of which 34 met the inclusion criteria. Thirty studies evaluated viremia and neurologic outcomes including 4 observational studies. Eight experimental studies examined viremia and abortion, which used the Ab4 and OH03 virus strains or recombinant Ab4 derivatives. Incidence rates for both EHM and abortion in experimental studies varied among the studies as did the level of evidence. Viremia was generally detectable before the onset of either EHM or abortion. Risk of bias was generally low to moderate, sample sizes were small, and multiple studies reported negative outcome data.Conclusions and Clinical ImportanceThe results of this study support that viremia is regularly present before EHM or abortion occurs. However, no inferences could be made about the relationship between the occurrence of either neurological signs or abortion and the magnitude or duration of viremia.}, journal={JOURNAL OF VETERINARY INTERNAL MEDICINE}, author={Soboll-Hussey, Gisela and Dorman, David C. and Burgess, Brandy A. and Goehring, Lutz and Gross, Peggy and Neinast, Claire and Osterrieder, Klaus and Pusterla, Nicola and Lunn, David P.}, year={2023}, month={Dec} } @article{osterrieder_dorman_burgess_goehring_gross_neinast_pusterla_hussey_lunn_2023, title={Vaccination for the prevention of equine herpesvirus-1 disease in domesticated horses: A systematic review and meta-analysis}, volume={11}, ISSN={["1939-1676"]}, url={https://doi.org/10.1111/jvim.16895}, DOI={10.1111/jvim.16895}, abstractNote={AbstractBackgroundEquine herpes virus type 1 (EHV‐1) infection in horses is associated with respiratory and neurologic disease, abortion, and neonatal death.HypothesisVaccines decrease the occurrence of clinical disease in EHV‐1‐infected horses.MethodsA systematic review was performed searching multiple databases to identify relevant studies. Selection criteria were original peer‐reviewed research reports that investigated the in vivo use of vaccines for the prevention of disease caused by EHV‐1 in domesticated horses. Main outcomes of interest included pyrexia, abortion, neurologic disease, viremia, and nasal shedding. We evaluated risk of bias, conducted exploratory meta‐analyses of incidence data for the main outcomes, and performed a GRADE evaluation of the quality of evidence for each vaccine subtype.ResultsA total of 1018 unique studies were identified, of which 35 met the inclusion criteria. Experimental studies accounted for 31/35 studies, with the remainder being observational studies. Eight vaccine subclasses were identified including commercial (modified‐live, inactivated, mixed) and experimental (modified‐live, inactivated, deletion mutant, DNA, recombinant). Risk of bias was generally moderate, often because of underreporting of research methods, and sample sizes were small leading to imprecision in the estimate of the effect size. Several studies reported either no benefit or minimal vaccine efficacy for the primary outcomes of interest. Meta‐analyses revealed significant heterogeneity was present, and our confidence in the quality of evidence for most outcomes was low to moderate.Conclusions and Clinical ImportanceOur review indicates that commercial and experimental vaccines minimally reduce the incidence of clinical disease associated with EHV‐1 infection.}, journal={JOURNAL OF VETERINARY INTERNAL MEDICINE}, author={Osterrieder, Klaus and Dorman, David C. and Burgess, Brandy A. and Goehring, Lutz S. and Gross, Peggy and Neinast, Claire and Pusterla, Nicola and Hussey, Gisela Soboll and Lunn, David P.}, year={2023}, month={Nov} } @article{pusterla_dorman_burgess_goehring_gross_osterrieder_soboll hussey_lunn_2023, title={Viremia and nasal shedding for the diagnosis of equine herpesvirus-1 infection in domesticated horses}, ISSN={["1939-1676"]}, url={https://doi.org/10.1111/jvim.16958}, DOI={10.1111/jvim.16958}, abstractNote={AbstractBackgroundEquine herpesvirus type 1 (EHV‐1) infection is associated with upper respiratory disease, EHM, abortions, and neonatal death.Research QuestionsAre nasal secretions a more sensitive biological sample compared to blood for the detection of EHV‐1 infection? How long is EHV‐1 detectable after primary infection by PCR?MethodsMedLine and Web of Science searches identified original peer‐reviewed reports evaluating nasal shedding and viremia using virus isolation methods or PCR published in English before October 9, 2023.ResultsSixty experimental and 20 observational studies met inclusion criteria. EHV‐1 detection frequency by qPCR in nasal secretions and blood from naturally‐infected horses with fever and respiratory signs were 15% and 9%, respectively; qPCR detection rates in nasal secretions and blood from horses with suspected EHM were 94% and 70%, respectively. In experimental studies the sensitivity of qPCR matched or exceeded that seen for virus isolation from either nasal secretions or blood. Detection of nasal shedding typically occurred within 2 days after EHV‐1 inoculation with a detection period of 3 to 7 days. Viremia lasted 2 to 7 days and was usually detected ≥1 days after positive identification of EHV‐1 in nasal secretions. Nasal shedding and viremia decreased over time and remained detectable in some horses for several weeks after inoculation.Conclusions and Clinical ImportanceUnder experimental conditions, blood and nasal secretions have similar sensitivity for the detection of EHV‐1 when horses are sampled on multiple consecutive days. In contrast, in observational studies detection of EHV‐1 in nasal secretions was consistently more successful.}, journal={JOURNAL OF VETERINARY INTERNAL MEDICINE}, author={Pusterla, Nicola and Dorman, David C. and Burgess, Brandy A. and Goehring, Lutz and Gross, Margaret and Osterrieder, Klaus and Soboll Hussey, Gisela and Lunn, David P.}, year={2023}, month={Dec} } @misc{hazel_mohan_gross_kattinakere sreedhara_shrestha_johnstone_marx_2021, title={Comparability of family planning quality of care measurement tools in low-and-middle income country settings: a systematic review}, volume={18}, ISSN={["1742-4755"]}, url={https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557007/?tool=EBI}, DOI={10.1186/s12978-021-01261-1}, abstractNote={Abstract Background In low-and-middle income countries (LMICs), accurate measures of the elements of quality care provided by a health worker through family planning services (also known as process quality) are required to ensure family’s contraceptives needs are being met. There are many tools used to assess family planning process quality of care (QoC) but no one standardized method. Those measuring QoC in LMICs should select an appropriate tool based the program context and financial/logistical parameters, but they require data on how well each tool measures routine clinical care. We aim to synthesize the literature on validity/comparability of family planning process QoC measurement tools through a quantitative systematic review with no meta-analysis. Methods We searched six literature databases for studies that compared quality measurements from different tools using quantitative statistics such as sensitivity/specificity, kappa statistic or absolute difference. We extracted the comparative measure along with other relevant study information, organized by quality indicator domain (e.g. counseling and privacy), and then classified the measure by low, medium, and high agreement. Results We screened 8172 articles and identified eight for analysis. Studies comparing quality measurements from simulated clients, direct observation, client exit interview, provider knowledge quizzes, and medical record review were included. These eight studies were heterogenous in their methods and the measurements compared. There was insufficient data to estimate overall summary measures of validity for the tools. Client exit interviews compared to direct observation or simulated client protocols had the most data and they were a poor proxy of the actual quality care received for many measurements. Conclusion To measure QoC consistently and accurately in LMICs, standardized tools and measures are needed along with an established method of combining them for a comprehensive picture of quality care. Data on how different tools proxy quality client care will inform these guidelines. Despite the small number of studies found during the review, we described important differences on how tools measure quality of care. }, number={1}, journal={REPRODUCTIVE HEALTH}, author={Hazel, Elizabeth and Mohan, Diwakar and Gross, Margaret and Kattinakere Sreedhara, Sushama and Shrestha, Prakriti and Johnstone, Maia and Marx, Melissa}, year={2021}, month={Oct} } @article{holroyd_schiaffino_chang_wanyiri_saldanha_gross_moss_hayford_2022, title={Diagnostic accuracy of dried blood spots for serology of vaccine-preventable diseases: a systematic review}, volume={1}, ISSN={["1744-8395"]}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-85122881850&partnerID=MN8TOARS}, DOI={10.1080/14760584.2022.2013821}, abstractNote={ABSTRACT Introduction Venous serum and plasma are optimal specimens for serological testing but may be logistically infeasible. Dried blood spots (DBS) are a feasible alternative, provided results are adequately sensitive and specific. We aimed to assess the diagnostic accuracy of DBS to measure IgG and IgM antibodies for vaccine-preventable diseases and compare test validity of DBS with venous blood. Areas covered In October 2020, we searched seven databases for peer-reviewed studies assessing the diagnostic accuracy of DBS specimens compared with serum in detecting antibodies to VPDs in humans. We extracted data and assessed risk of bias in all included studies. We calculated sensitivity and specificity with 95% confidence intervals for each index-reference test comparison. We narratively synthesized the identified evidence on diagnostic accuracy and blood collection and processing methods for DBS. Studies on measles and rubella IgG and IgM were the most frequently identified and reported generally high sensitivity and specificity. Expert opinion Lack of standardization in collection, storage, and testing methods limited systematic comparison across studies. Our findings indicate a need for additional validation studies on the diagnostic accuracy of DBS to expand their use in serological surveillance. We recommend practical considerations to improve standardized reporting for DBS validation studies.}, note={Epub ahead of print. PMID: 34852211.}, number={2}, journal={EXPERT REVIEW OF VACCINES}, author={Holroyd, Taylor A. and Schiaffino, Francesca and Chang, Rachel H. and Wanyiri, Jane W. and Saldanha, Ian J. and Gross, Margaret and Moss, William J. and Hayford, Kyla}, year={2022}, month={Jan} } @misc{ghazaryan_delarmente_garber_gross_sriudomporn_rao_2021, title={Effectiveness of hospital payment reforms in low- and middle-income countries: a systematic review}, volume={36}, ISSN={["1460-2237"]}, url={http://dx.doi.org/10.1093/heapol/czab050}, DOI={10.1093/heapol/czab050}, abstractNote={Abstract Payment mechanisms have attracted substantial research interest because of their consequent effect on care outcomes, including treatment costs, admission and readmission rates and patient satisfaction. Those mechanisms create the incentive environment within which health workers operate and can influence provider behaviour in ways that can facilitate achievement of national health policy goals. This systematic review aims to understand the effects of changes in hospital payment mechanisms introduced in low- and middle-income countries (LMICs) on hospital- and patient-level outcomes. A standardised search of seven databases and a manual search of the grey literature and reference lists of existing reviews were performed to identify relevant articles published between January 2000 and July 2019. We included original studies focused on hospital payment reforms and their effect on hospital and patient outcomes in LMICs. Narrative descriptions or studies focusing only on provider payments or primary care settings were excluded. The authors used the Risk of Bias in Non-Randomized Studies of Interventions tool to assess the risk of bias and quality. Results were synthesized in a narrative description due to methodological heterogeneity. A total of 24 articles from seven middle-income countries were included, the majority of which are from Asia. In most cases, hospital payment reforms included shifts from passive (fee-for-service) to active payment models—the most common being diagnosis-related group payments, capitation and global budget. In general, hospital payment reforms were associated with decreases in hospital expenditures, out-of-pocket payments, length of hospital stay and readmission rates. The majority of the articles scored low on quality due to weak study design. A shift from passive to active hospital payment methods in LMICs has been associated with lower hospital and patient costs as well as increased efficiency without any apparent compromise on quality. However, there is an important need for high-quality studies in this area.}, number={8}, journal={HEALTH POLICY AND PLANNING}, publisher={Oxford University Press (OUP)}, author={Ghazaryan, Emma and Delarmente, Benjo A. and Garber, Kent and Gross, Margaret and Sriudomporn, Salin and Rao, Krishna D.}, year={2021}, month={Oct}, pages={1344–1356} } @article{broucker_sim_brenzel_gross_patenaude_constenla_2020, title={Cost of Nine Pediatric Infectious Illnesses in Low- and Middle-Income Countries: A Systematic Review of Cost-of-Illness Studies}, volume={38}, url={https://doi.org/10.1007/s40273-020-00940-4}, DOI={10.1007/s40273-020-00940-4}, abstractNote={Abstract Background Cost-of-illness data from empirical studies provide insights into the use of healthcare resources including both expenditures and the opportunity cost related to receiving treatment. Objective The objective of this systematic review was to gather cost data and relevant parameters for hepatitis B, pneumonia, meningitis, encephalitis caused by Japanese encephalitis, rubella, yellow fever, measles, influenza, and acute gastroenteritis in children in low- and middle-income countries. Data Sources Peer-reviewed studies published in public health, medical, and economic journals indexed in PubMed (MEDLINE), Embase, and EconLit. Study Eligibility Criteria, Participants, and Interventions Studies must (1) be peer reviewed, (2) be published in 2000–2016, (3) provide cost data for one of the nine diseases in children aged under 5 years in low- and middle-income countries, and (4) generated from primary data collection. Limitations We cannot exclude missing a few articles in our review. Measures were taken to reduce this risk. Several articles published since 2016 are omitted from the systematic review results, these articles are included in the discussion. Conclusions and Implications of Key Findings The review yielded 37 articles and 267 sets of cost estimates. We found no cost-of-illness studies with cost estimates for hepatitis B, measles, rubella, or yellow fever from primary data. Most estimates were from countries in Gavi preparatory (28%) and accelerated (28%) transition, followed by those who are initiating self-financing (22%) and those not eligible for Gavi support (19%). Thirteen articles compared household expenses to manage illnesses with income and two articles with other household expenses, such as food, clothing, and rent. An episode of illness represented 1–75% of the household’s monthly income or 10–83% of its monthly expenses. Articles that presented both household and government perspectives showed that most often governments incurred greater costs than households, including non-medical and indirect costs, across countries of all income statuses, with a few notable exceptions. Although limited for low- and middle-income country settings, cost estimates generated from primary data collection provided a ‘real-world’ estimate of the economic burden of vaccine-preventable diseases. Additional information on whether common situations preventing the application of official clinical guidelines (such as medication stock-outs) occurred would help reveal deficiencies in the health system. Improving the availability of cost-of-illness evidence can inform the public policy agenda about healthcare priorities and can help to operationalize the healthcare budget in local health systems to respond adequately to the burden of illness in the community. }, number={10}, journal={PharmacoEconomics}, publisher={Springer Science and Business Media LLC}, author={Broucker, Gatien and Sim, So Yoon and Brenzel, Logan and Gross, Margaret and Patenaude, Bryan and Constenla, Dagna O.}, year={2020}, month={Oct}, pages={1071–1094} } @article{beckham_crossnohere_gross_bridges_2021, title={Eliciting Preferences for HIV Prevention Technologies: A Systematic Review}, volume={14}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-85100830610&partnerID=MN8TOARS}, DOI={10.1007/s40271-020-00486-9}, abstractNote={Many human immunodeficiency virus (HIV) prevention technologies (pre-exposure prophylaxis, microbicides, vaccines) are available or in development. Preference elicitation methods provide insight into client preferences that may be used to optimize products and services. Given increased utilization of such methods in HIV prevention, this article identifies and reviews these methods and synthesizes their application to HIV prevention technologies.In May 2020, we systematically searched peer-reviewed literature in PubMed, CINAHL, and Web of Science for studies employing quantitative preference elicitation methods to measure preferences for HIV prevention technologies among populations of any age, sex, or location. Quality assessment used an existing checklist (PREFS) and a novel adaptation of the Newcastle-Ottawa Scale (PROSPERO #CRD42018087027).We screened 5022 titles and abstracts, reviewed 318 full texts, and included 84 studies. Common methods employed were discrete-choice experiment (33%), conjoint analysis (25%), and willingness-to-participate/try/accept (21%). Studies were conducted in 25 countries and had a mean of 768 participants (range = 26-7176), two-thirds of them male. Common HIV prevention technologies included pre-exposure prophylaxis (23%), voluntary testing and counseling (19%), HIV self-testing (17%), vaccines (15%), and topical microbicides (9%). Most attributes focused on product design (side effects, frequency), service design (provider type, location), acceptability or willingness to accept/pay; results are summarized in these categories, by prevention type. Mean quality-adapted Newcastle-Ottawa Scale score was 4.5/8 (standard deviation = 2.1) and mean PREFS scores was 3.47/5 (standard deviation = 0.81).This review synthesizes extant literature on quantitative measurement of preferences for HIV prevention technologies. This can enable practitioners to improve prevention products and interventions, and ultimately reduce HIV incidence.}, number={2}, journal={Patient}, author={Beckham, S.W. and Crossnohere, N.L. and Gross, M. and Bridges, J.F.P.}, year={2021}, pages={151–174} } @book{organization_2020, title={What do we know about community health workers? A systematic review of existing reviews}, url={https://apps.who.int/iris/handle/10665/340717}, publisher={World Health Organization}, author={Organization, World Health}, year={2020}, pages={x, 74 p.} } @inproceedings{rosman_gross_nanavati_twose_2018, title={Crossing the chasm: Library curriculum courses in a school of public health offer equal opportunity in the online environment}, booktitle={American Public Health Association}, author={Rosman, L. and Gross, M. and Nanavati, J. and Twose, C.}, year={2018}, month={Nov} } @article{garcia-larsen_nie_gross_waidyatillake_2018, title={Dietary risk factors for poor lung function and chronic obstructive pulmonary disease (COPD) in low and middle income countries}, url={http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018093518}, journal={PROSPERO}, author={Garcia-Larsen, Vanessa and Nie, Jianyi and Gross, Peggy and Waidyatillake, Nilakshi}, year={2018}, month={Apr}, pages={42018093518} } @inproceedings{hayford_wanyiri_moss_saldana_gross_waldrop_2018, place={Bethesda, MD}, title={Systematic review of the diagnostic accuracy, validity, and acceptability of oral fluids and capillary blood for measurement of antibodies to vaccine preventable infectious diseases}, booktitle={Conference on Vaccinology Research}, year={2018}, month={Apr} } @article{scott_beckham_gross_pariyo_rao_cometto_perry_2018, title={What do we know about community-based health worker programs? A systematic review of existing reviews on community health workers}, volume={16}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-85051998269&partnerID=MN8TOARS}, DOI={10.1186/s12960-018-0304-x}, abstractNote={To synthesize current understanding of how community-based health worker (CHW) programs can best be designed and operated in health systems. We searched 11 databases for review articles published between 1 January 2005 and 15 June 2017. Review articles on CHWs, defined as non-professional paid or volunteer health workers based in communities, with less than 2 years of training, were included. We assessed the methodological quality of the reviews according to AMSTAR criteria, and we report our findings based on PRISMA standards. We identified 122 reviews (75 systematic reviews, of which 34 are meta-analyses, and 47 non-systematic reviews). Eighty-three of the included reviews were from low- and middle-income countries, 29 were from high-income countries, and 10 were global. CHW programs included in these reviews are diverse in interventions provided, selection and training of CHWs, supervision, remuneration, and integration into the health system. Features that enable positive CHW program outcomes include community embeddedness (whereby community members have a sense of ownership of the program and positive relationships with the CHW), supportive supervision, continuous education, and adequate logistical support and supplies. Effective integration of CHW programs into health systems can bolster program sustainability and credibility, clarify CHW roles, and foster collaboration between CHWs and higher-level health system actors. We found gaps in the review evidence, including on the rights and needs of CHWs, on effective approaches to training and supervision, on CHWs as community change agents, and on the influence of health system decentralization, social accountability, and governance. Evidence concerning CHW program effectiveness can help policymakers identify a range of options to consider. However, this evidence needs to be contextualized and adapted in different contexts to inform policy and practice. Advancing the evidence base with context-specific elements will be vital to helping these programs achieve their full potential.}, number={1}, journal={Human Resources for Health}, author={Scott, K. and Beckham, S.W. and Gross, M. and Pariyo, G. and Rao, K.D. and Cometto, G. and Perry, H.B.}, year={2018} } @inproceedings{scott_beckham_gross_pariyo_rao_cometto_by the world health organization_2017, title={What do we know about community-based practitioner programs? A systematic review of reviews on community health workers and their integration with health systems." }, note={Contributed paper. Dublin, Ireland. November 14, 2017.}, booktitle={Fourth Global Forum on Human Resources for Health}, author={Scott, Kerry and Beckham, Sarah and Gross, Margaret and Pariyo, George and Rao, Krishna and Cometto, Giorgio and World Health Organization, Henry B.Perry Commissioned by the}, year={2017}, month={Nov} } @inproceedings{gross_blanck_hesson_minter_rosman_twose_seymour_2015, place={Boston, Massachusetts, March}, title={Information Seeking Needs and Behaviors for Global Health: Mapping Welch Medical Library's Global Health Information Services.}, booktitle={Consortium of Universities for Global Health Conference}, author={Gross, M. and Blanck, J.F. and Hesson, D.D. and Minter, C.I.J. and Rosman, L. and Twose, C. and Seymour, A.K.}, year={2015}, month={Mar}, pages={26–28,} } @inproceedings{blanck_a.k._m._d.d._c.i.j._h.j._twose_2015, place={Austin, TX}, title={Logical Empowerment: Using a Mixed-Method Participatory Approach to Identify Information Services and Resources that Support Global Health.}, volume={16}, booktitle={Annual Meeting of the Medical Library Association}, author={Blanck, J.F.Seymour and A.K., Gross and M., Hesson and D.D., Minter and C.I.J., Thompson and H.J. and Twose, C.J.}, year={2015}, month={May}, pages={– 20,} } @article{pereda_chavez_hooper-miele_gilman_steinhoff_ellington_gross_price_tielsch_checkley_2015, title={Lung ultrasound for the diagnosis of pneumonia in children: A meta-analysis}, volume={135}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-84927740670&partnerID=MN8TOARS}, DOI={10.1542/peds.2014-2833}, abstractNote={ BACKGROUND AND OBJECTIVE: Pneumonia is the leading cause of death of children. Diagnostic tools include chest radiography, but guidelines do not currently recommend the use of lung ultrasound (LUS) as a diagnostic method. We conducted a meta-analysis to summarize evidence on the diagnostic accuracy of LUS for childhood pneumonia. METHODS: We performed a systematic search in PubMed, Embase, the Cochrane Library, Scopus, Global Health, World Health Organization–Libraries, and Latin American and Caribbean Health Sciences Literature of studies comparing LUS diagnostic accuracy against a reference standard. We used a combination of controlled key words for age <18 years, pneumonia, and ultrasound. We identified 1475 studies and selected 15 (1%) for further review. Eight studies (765 children) were retrieved for analysis, of which 6 (75%) were conducted in the general pediatric population and 2 (25%) in neonates. Eligible studies provided information to calculate sensitivity, specificity, and positive and negative likelihood ratios. Heterogeneity was assessed by using Q and I2 statistics. RESULTS: Five studies (63%) reported using highly skilled sonographers. Overall methodologic quality was high, but heterogeneity was observed across studies. LUS had a sensitivity of 96% (95% confidence interval [CI]: 94%–97%) and specificity of 93% (95% CI: 90%–96%), and positive and negative likelihood ratios were 15.3 (95% CI: 6.6–35.3) and 0.06 (95% CI: 0.03–0.11), respectively. The area under the receiver operating characteristic curve was 0.98. Limitations included the following: most studies included in our analysis had a low number of patients, and the number of eligible studies was also small. CONCLUSIONS: Current evidence supports LUS as an imaging alternative for the diagnosis of childhood pneumonia. Recommendations to train pediatricians on LUS for diagnosis of pneumonia may have important implications in different clinical settings. }, number={4}, journal={Pediatrics}, author={Pereda, M.A. and Chavez, M.A. and Hooper-Miele, C.C. and Gilman, R.H. and Steinhoff, M.C. and Ellington, L.E. and Gross, M. and Price, C. and Tielsch, J.M. and Checkley, W.}, year={2015}, pages={714–722} } @article{chavez_shams_ellington_naithani_gilman_steinhoff_santosham_black_price_gross_et al._2014, title={Lung ultrasound for the diagnosis of pneumonia in adults: A systematic review and meta-analysis}, volume={15}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-84899911053&partnerID=MN8TOARS}, DOI={10.1186/1465-9921-15-50}, abstractNote={Guidelines do not currently recommend the use of lung ultrasound (LUS) as an alternative to chest X-ray (CXR) or chest computerized tomography (CT) scan for the diagnosis of pneumonia. We conducted a meta-analysis to summarize existing evidence of the diagnostic accuracy of LUS for pneumonia in adults. We conducted a systematic search of published studies comparing the diagnostic accuracy of LUS against a referent CXR or chest CT scan and/or clinical criteria for pneumonia in adults aged ≥18 years. Eligible studies were required to have a CXR and/or chest CT scan at the time of evaluation. We manually extracted descriptive and quantitative information from eligible studies, and calculated pooled sensitivity and specificity using the Mantel-Haenszel method and pooled positive and negative likelihood ratios (LR) using the DerSimonian-Laird method. We assessed for heterogeneity using the Q and I2 statistics. Our initial search strategy yielded 2726 articles, of which 45 (1.7%) were manually selected for review and 10 (0.4%) were eligible for analyses. These 10 studies provided a combined sample size of 1172 participants. Six studies enrolled adult patients who were either hospitalized or admitted to Emergency Departments with suspicion of pneumonia and 4 studies enrolled critically-ill adult patients. LUS was performed by highly-skilled sonographers in seven studies, by trained physicians in two, and one did not mention level of training. All studies were conducted in high-income settings. LUS took a maximum of 13 minutes to conduct. Nine studies used a 3.5-5 MHz micro-convex transducer and one used a 5–9 MHz convex probe. Pooled sensitivity and specificity for the diagnosis of pneumonia using LUS were 94% (95% CI, 92%-96%) and 96% (94%-97%), respectively; pooled positive and negative LRs were 16.8 (7.7-37.0) and 0.07 (0.05-0.10), respectively; and, the area-under-the-ROC curve was 0.99 (0.98-0.99). Our meta-analysis supports that LUS, when conducted by highly-skilled sonographers, performs well for the diagnosis of pneumonia. General practitioners and Emergency Medicine physicians should be encouraged to learn LUS since it appears to be an established diagnostic tool in the hands of experienced physicians.}, number={1}, journal={Respiratory Research}, author={Chavez, M.A. and Shams, N. and Ellington, L.E. and Naithani, N. and Gilman, R.H. and Steinhoff, M.C. and Santosham, M. and Black, R.E. and Price, C. and Gross, M. and et al.}, year={2014} } @inproceedings{twose_rosman_gross_hesson_adamo_li_saldanha_vedula_dickersin_2013, place={Boston, MA}, title={An Interdisciplinary Collaboration to Teach Systematic Review Methods}, booktitle={Contributed Paper. Medical Library Association Annual Meeting}, author={Twose, C. and Rosman, L. and Gross, P. and Hesson, D. and Adamo, J. and Li, T. and Saldanha, I. and Vedula, S. and Dickersin, K.}, year={2013}, month={May} } @inproceedings{gross_wright_2013, place={Baltimore, MD}, title={Welch Medical Library Bioinformatics Portal}, booktitle={Seventh Annual Young Investigators Symposium on Genomics and Bioinformatics. Poster Presentation}, author={Gross, P. and Wright, R.}, year={2013}, month={Oct} } @inproceedings{wright_gross_2012, place={Baltimore, MD}, title={Bioinformatics Support Services. Sixth Annual Young Investigators Symposium on Genomics and Bioinformatics. }, booktitle={Sixth Annual Young Investigators Symposium on Genomics and Bioinformatics. Poster Presentation}, author={Wright, R. and Gross, P.}, year={2012}, month={Oct} } @inproceedings{saati_ogunsanya_gross_towse_saber-tehrani_omron_melnick_lehmann_newman toker_2012, place={Baltimore, MD}, title={Diagnostic Computerized Decision Support Systems in the Emergency Department: A Systematic Review. }, booktitle={Diagnostic Errors in Medicine: 5th International Conference. Poster Presentation}, author={Saati, A. and Ogunsanya, O. and Gross, P. and Towse, C. and Saber-Tehrani, A. and Omron, R. and Melnick, T. and Lehmann, H. and Newman Toker, D.}, year={2012}, month={Nov} } @article{gross_goode_2012, title={The informationist's role in 21st century medicine.}, volume={13}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-84866463842&partnerID=MN8TOARS}, number={1}, journal={Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society}, author={Gross, M. and Goode, V.H.}, year={2012}, pages={27–28} } @inproceedings{gross_2011, place={Minneapolis, MN}, title={Making Sense of Breast and Ovarian Cancer in Minority Populations: Online Information Seeking by First-Degree Relatives.}, booktitle={Medical Library Association Annual Meeting Contributed Paper}, author={Gross, M.}, year={2011}, month={May} } @inproceedings{currie_gross_2010, place={Chapel Hill, NC}, title={Sister, Sister: Rethinking Sense-Making Theory through Consciousness-Raising}, publisher={Contributed Paper. Medical Library Association-MAR}, author={Currie, L. and Gross, M.Sister}, year={2010}, month={Oct} }